Fuchu, Japan

Tomiaki Morimoto


Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Fuchu, JP (1979)
  • Hino, JP (1986)
  • Tokyo, JP (1988)

Company Filing History:


Years Active: 1979-1988

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Tomiaki Morimoto

Introduction

Tomiaki Morimoto is a notable inventor based in Fuchu, Japan. He has made significant contributions to the field of immunoassays, particularly in the measurement of substances related to adult T cell leukemia. With a total of 3 patents to his name, Morimoto's work has had a considerable impact on medical diagnostics.

Latest Patents

Morimoto's latest patents include a method for measuring substances by enzyme immunoassay. This improved method allows for the simultaneous measurement of multiple specimens of a substance to be measured by enzyme immunoassay. Another significant patent is the process for producing an adult T cell leukemia associated antigen. This process involves treating an adult T cell leukemia associated antigen producing cell with a surfactant. Additionally, he has developed a method for assaying adult T cell leukemia associated antibodies using enzymoimmunoassay, radioimmunoassay, or passive hemagglutination. In this method, the antigen obtained from the treated cells is utilized in the assay procedure.

Career Highlights

Tomiaki Morimoto is currently associated with Eisai Company, Limited, where he continues to innovate in the field of medical research. His work has been instrumental in advancing diagnostic techniques for serious health conditions.

Collaborations

Some of Morimoto's notable coworkers include Takashi Sawada and Toyohiro Kitamura. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Tomiaki Morimoto's contributions to the field of immunoassays and his innovative patents highlight his importance as an inventor. His work continues to influence medical diagnostics and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…